Suppr超能文献

经皮全心室辅助装置植入术治疗暴发性心肌炎。

Total percutaneous biventricular assist device implantation for fulminant myocarditis.

机构信息

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Yamadaoka, 2-2, Suita, Osaka, 565-0871, Japan.

Department of Cardiology, Osaka University Graduate School of Medicine, Osaka, Japan.

出版信息

J Artif Organs. 2021 Jun;24(2):254-257. doi: 10.1007/s10047-020-01197-6. Epub 2020 Aug 4.

Abstract

We report an effective therapeutic approach of mechanical circulatory support for a patient with cardiogenic shock and respiratory insufficiency due to fulminant myocarditis. An Impella 5.0 was utilized as a left ventricular assist device (VAD) and percutaneous veno-pulmonary extracorporeal membrane oxygenation (ECMO) as a right VAD. These devices were implanted without sternotomy or thoracotomy. Although a combination of Impella and veno-arterial ECMO has been reported as percutaneous biventricular support, there are concerns that this combination is not beneficial for myocardial recovery in patients with respiratory insufficiency, because Impella expels insufficiently oxygenated blood from the left ventricle to the coronary arteries. Our approach took advantage of percutaneous implantation of ECMO and temporary VAD, eliminating the drawbacks of both devices, thus providing a more effective and less invasive form of temporary biventricular support.

摘要

我们报告了一种机械循环支持的有效治疗方法,用于治疗因暴发性心肌炎导致心源性休克和呼吸功能不全的患者。使用 Impella 5.0 作为左心室辅助装置(VAD),并经皮置入静脉-肺动脉体外膜肺氧合(ECMO)作为右 VAD。这些设备无需开胸或开胸即可植入。尽管已经有报道称 Impella 和 veno-arterial ECMO 的联合应用可作为经皮双心室支持,但有人担心这种联合应用对呼吸功能不全患者的心肌恢复没有益处,因为 Impella 将含氧不足的血液从左心室排出到冠状动脉。我们的方法利用了 ECMO 和临时 VAD 的经皮植入,消除了这两种设备的缺点,从而提供了一种更有效和微创的临时双心室支持形式。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验